Benchmark’s Bill Gurley: Bubble Looms Over AI Rally
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
Price weighting biases index behavior differently than market-cap methods. This overview explains the mechanics and the practical impact on portfolio results.
25,572 articlesA seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
Apple sidesteps the AI capex race, prioritizing software and on-device AI. Analysts see a bigger iPhone upgrade cycle...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Trump endorses ethics restrictions tied to the CLARITY Act, handing Democrats a pivotal decision on crypto oversight....
GameStop is weighing a bold move: acquiring eBay. This article breaks down whether does Gamestop's proposed acquisiti...
This article dives into why this dividend stock's moat offers unparalleled stability for long-term investors. Discove...
As Absci releases its 2026 earnings outlook, investors gain a clearer view of runway, milestones, and collaboration p...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
A new financial snapshot shows the United States still leads in global finance even as diplomatic ties evolve. The yu...
Jaguar (JAGX) 2025 earnings show a company shifting from product-driven revenue to licensing cash. This piece breaks ...
Jaguar Health faces a pivotal year as its key drug Mytesi and pipeline shape 2025 outcomes. This guide breaks down Q3...
Two major travel stocks have caught the eye of billionaire activist investors. This article breaks down what could ha...